139 related articles for article (PubMed ID: 35179048)
1. Plasma neurofilament light chain protein is not increased in treatment-resistant schizophrenia and first-degree relatives.
Eratne D; Janelidze S; Malpas CB; Loi S; Walterfang M; Merritt A; Diouf I; Blennow K; Zetterberg H; Cilia B; Wannan C; Bousman C; Everall I; Zalesky A; Jayaram M; Thomas N; Berkovic SF; Hansson O; Velakoulis D; Pantelis C; Santillo A;
Aust N Z J Psychiatry; 2022 Oct; 56(10):1295-1305. PubMed ID: 35179048
[TBL] [Abstract][Full Text] [Related]
2. Plasma neurofilament light in behavioural variant frontotemporal dementia compared to mood and psychotic disorders.
Eratne D; Kang M; Malpas C; Simpson-Yap S; Lewis C; Dang C; Grewal J; Coe A; Dobson H; Keem M; Chiu WH; Kalincik T; Ooi S; Darby D; Brodtmann A; Hansson O; Janelidze S; Blennow K; Zetterberg H; Walker A; Dean O; Berk M; Wannan C; Pantelis C; Loi SM; Walterfang M; Berkovic SF; Santillo AF; Velakoulis D
Aust N Z J Psychiatry; 2024 Jan; 58(1):70-81. PubMed ID: 37477141
[TBL] [Abstract][Full Text] [Related]
3. Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders.
Olsson B; Portelius E; Cullen NC; Sandelius Å; Zetterberg H; Andreasson U; Höglund K; Irwin DJ; Grossman M; Weintraub D; Chen-Plotkin A; Wolk D; McCluskey L; Elman L; Shaw LM; Toledo JB; McBride J; Hernandez-Con P; Lee VM; Trojanowski JQ; Blennow K
JAMA Neurol; 2019 Mar; 76(3):318-325. PubMed ID: 30508027
[TBL] [Abstract][Full Text] [Related]
4. Neurofilament light chain as a blood biomarker to differentiate psychiatric disorders from behavioural variant frontotemporal dementia.
Al Shweiki MR; Steinacker P; Oeckl P; Hengerer B; Danek A; Fassbender K; Diehl-Schmid J; Jahn H; Anderl-Straub S; Ludolph AC; Schönfeldt-Lecuona C; Otto M
J Psychiatr Res; 2019 Jun; 113():137-140. PubMed ID: 30953863
[TBL] [Abstract][Full Text] [Related]
5. A pilot study of the utility of cerebrospinal fluid neurofilament light chain in differentiating neurodegenerative from psychiatric disorders: A 'C-reactive protein' for psychiatrists and neurologists?
Eratne D; Loi SM; Walia N; Farrand S; Li QX; Varghese S; Walterfang M; Evans A; Mocellin R; Dhiman K; Gupta V; Malpas CB; Collins S; Masters CL; Velakoulis D
Aust N Z J Psychiatry; 2020 Jan; 54(1):57-67. PubMed ID: 31220922
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid neurofilament light chain differentiates behavioural variant frontotemporal dementia progressors from non-progressors.
Eratne D; Keem M; Lewis C; Kang M; Walterfang M; Farrand S; Loi S; Kelso W; Cadwallader C; Berkovic SF; Li QX; Masters CL; Collins S; Santillo A; Velakoulis D;
J Neurol Sci; 2022 Nov; 442():120439. PubMed ID: 36201960
[TBL] [Abstract][Full Text] [Related]
7. Neurofilament-light chain quantification by Simoa and Ella in plasma from patients with dementia: a comparative study.
Truffi M; Garofalo M; Ricciardi A; Cotta Ramusino M; Perini G; Scaranzin S; Gastaldi M; Albasini S; Costa A; Chiavetta V; Corsi F; Morasso C; Gagliardi S
Sci Rep; 2023 Mar; 13(1):4041. PubMed ID: 36899015
[TBL] [Abstract][Full Text] [Related]
8. Plasma Neurofilament Light Chain and Clinical Diagnosis in Frontotemporal Dementia Syndromes.
Ooi S; Patel SK; Eratne D; Kyndt C; Reidy N; Lewis C; Lee SCM; Darby D; Brodtmann A
J Alzheimers Dis; 2022; 89(4):1221-1231. PubMed ID: 35988220
[TBL] [Abstract][Full Text] [Related]
9. Thirty years after anorexia nervosa onset, serum neurofilament light chain protein concentration indicates neuronal injury.
Wentz E; Dobrescu SR; Dinkler L; Gillberg C; Gillberg C; Blennow K; Råstam M; Zetterberg H
Eur Child Adolesc Psychiatry; 2021 Dec; 30(12):1907-1915. PubMed ID: 33040187
[TBL] [Abstract][Full Text] [Related]
10. The role of neurofilament light chain in frontotemporal dementia: a meta-analysis.
Karantali E; Kazis D; Chatzikonstantinou S; Petridis F; Mavroudis I
Aging Clin Exp Res; 2021 Apr; 33(4):869-881. PubMed ID: 32306372
[TBL] [Abstract][Full Text] [Related]
11. Plasma neurofilament light chain is not elevated in people with first-episode psychosis or those at ultra-high risk for psychosis.
Kang MJY; Eratne D; Wannan C; Santillo AF; Velakoulis D; Pantelis C; Cropley V
Schizophr Res; 2024 May; 267():269-272. PubMed ID: 38581830
[TBL] [Abstract][Full Text] [Related]
12. Neurofilament light chain protein in neurodegenerative dementia: A systematic review and network meta-analysis.
Zhao Y; Xin Y; Meng S; He Z; Hu W
Neurosci Biobehav Rev; 2019 Jul; 102():123-138. PubMed ID: 31026486
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia.
Landqvist Waldö M; Frizell Santillo A; Passant U; Zetterberg H; Rosengren L; Nilsson C; Englund E
BMC Neurol; 2013 May; 13():54. PubMed ID: 23718879
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid neurofilament light and cerebral atrophy in younger-onset dementia and primary psychiatric disorders.
Walia N; Eratne D; Loi SM; Farrand S; Li QX; Malpas CB; Varghese S; Walterfang M; Evans AH; Parker S; Collins SJ; Masters CL; Velakoulis D
Intern Med J; 2023 Sep; 53(9):1564-1569. PubMed ID: 36314730
[TBL] [Abstract][Full Text] [Related]
15. Comparison of CSF and serum neurofilament light and heavy chain as differential diagnostic biomarkers for ALS.
Halbgebauer S; Steinacker P; Verde F; Weishaupt J; Oeckl P; von Arnim C; Dorst J; Feneberg E; Mayer B; Rosenbohm A; Silani V; Ludolph AC; Otto M
J Neurol Neurosurg Psychiatry; 2022 Jan; 93(1):68-74. PubMed ID: 34417339
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid neurofilament light levels in neurodegenerative dementia: Evaluation of diagnostic accuracy in the differential diagnosis of prion diseases.
Zerr I; Schmitz M; Karch A; Villar-Piqué A; Kanata E; Golanska E; Díaz-Lucena D; Karsanidou A; Hermann P; Knipper T; Goebel S; Varges D; Sklaviadis T; Sikorska B; Liberski PP; Santana I; Ferrer I; Zetterberg H; Blennow K; Calero O; Calero M; Ladogana A; Sánchez-Valle R; Baldeiras I; Llorens F
Alzheimers Dement; 2018 Jun; 14(6):751-763. PubMed ID: 29391125
[TBL] [Abstract][Full Text] [Related]
17. Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study.
de Wolf F; Ghanbari M; Licher S; McRae-McKee K; Gras L; Weverling GJ; Wermeling P; Sedaghat S; Ikram MK; Waziry R; Koudstaal W; Klap J; Kostense S; Hofman A; Anderson R; Goudsmit J; Ikram MA
Brain; 2020 Apr; 143(4):1220-1232. PubMed ID: 32206776
[TBL] [Abstract][Full Text] [Related]
18. Serum neurofilament light chain is a discriminative biomarker between frontotemporal lobar degeneration and primary psychiatric disorders.
Katisko K; Cajanus A; Jääskeläinen O; Kontkanen A; Hartikainen P; Korhonen VE; Helisalmi S; Haapasalo A; Koivumaa-Honkanen H; Herukka SK; Remes AM; Solje E
J Neurol; 2020 Jan; 267(1):162-167. PubMed ID: 31595378
[TBL] [Abstract][Full Text] [Related]
19. The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias.
Abu-Rumeileh S; Capellari S; Stanzani-Maserati M; Polischi B; Martinelli P; Caroppo P; Ladogana A; Parchi P
Alzheimers Res Ther; 2018 Jan; 10(1):3. PubMed ID: 29368621
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid neurofilament light predicts longitudinal diagnostic change in patients with psychiatric and neurodegenerative disorders.
Kang MJY; Eratne D; Dobson H; Malpas CB; Keem M; Lewis C; Grewal J; Tsoukra V; Dang C; Mocellin R; Kalincik T; Santillo AF; Zetterberg H; Blennow K; Stehmann C; Varghese S; Li QX; Masters CL; Collins S; Berkovic SF; Evans A; Kelso W; Farrand S; Loi SM; Walterfang M; Velakoulis D
Acta Neuropsychiatr; 2024 Feb; 36(1):17-28. PubMed ID: 37114460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
